Financial statement analysis and common stock valuation
Financial Analyst
Stock Analysis on Net
If you are an investor who values fundamental analysis, you are in the right place. If you need comprehensive financial ratios, read on. You already know that the analysis of financial statements allows you to buy cheap and sell high, now it’s time to put it into practice. Stock Analysis on Net is here for you.
Today, try for free:
Thermo Fisher Scientific Inc. (NYSE:TMO)
Common-Size Balance Sheet: Assets
Quarterly Data
Assets components shown as percentage of total assets.
Analysis of Short-term (Operating) Activity Ratios
Quarterly Data
Evaluates revenues and output generated by the Thermo Fisher Scientific Inc. assets. Operating performance ratios describe the relationship between the Thermo Fisher Scientific Inc. level of operations and the assets needed to sustain operating activities.
Balance Sheet: Assets
The assets reports major classes and amounts of resources owned or controlled by Thermo Fisher Scientific Inc..
Common-Size Balance Sheet: Assets
Assets components shown as percentage of total assets.
Long-term Trends
Enterprise Value to EBITDA (EV/EBITDA)
To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital.
DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
An approach to decomposing Thermo Fisher Scientific Inc. return on equity, return on assets, and net profit margin ratio as the product of other financial ratios.
Enterprise Value to FCFF (EV/FCFF)
Free cash flow to the firm is the cash flow available to the Thermo Fisher Scientific Inc. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made.
Aggregate Accruals
Financial reporting quality relates to the accuracy with which Thermo Fisher Scientific Inc. reported financial statements reflect its operating performance and to their usefulness for forecasting future cash flows.
Aggregate accruals deriving measures of the accrual component of Thermo Fisher Scientific Inc. earnings.
Common Stock Valuation Ratios
Quarterly Data
Relative valuation technique determine the value of Thermo Fisher Scientific Inc. by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock value, such as earnings, book value, and sales.
DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data
An approach to decomposing Thermo Fisher Scientific Inc. return on equity, return on assets, and net profit margin ratio as the product of other financial ratios.
Capital Asset Pricing Model (CAPM)
CAPM is a theory concentrated with deriving the expected rates of return on risky assets based on the assets’ systematic risk levels. Systematic risk is the variability of returns that is due to macroeconomic factors that affect all risky assets. It cannot be eliminated by diversification.
Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Liabilities and stockholders’ equity components shown as percentage of total liabilities and stockholders’ equity.
What’s new
Monday, June 22, 2026
Oracle Corp. (NYSE:ORCL) annual report
for fiscal year ended May 31, 2026
Thursday, June 18, 2026
Medtronic PLC (NYSE:MDT) annual report
for fiscal year ended April 24, 2026
Thursday, June 18, 2026
Accenture PLC (NYSE:ACN) quarterly report
for quarterly period ended May 31, 2026
Monday, June 15, 2026
Adobe Inc. (NASDAQ:ADBE) quarterly report
for quarterly period ended May 29, 2026
Tuesday, June 9, 2026
Broadcom Inc. (NASDAQ:AVGO) quarterly report
for quarterly period ended May 3, 2026
Tuesday, June 9, 2026
Dell Technologies Inc. (NYSE:DELL) quarterly report
for quarterly period ended May 1, 2026